You are here

Article Text

Article menu
Download PDFPDF
Recent advances in clinical practice
Benefits of lifestyle modification in NAFLD

https://doi.org/10.1136/gut.2006.112094

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or reflecting the view of the Department of the Army or the Department of Defense.

    • Competing interests: CPD has acted as a consultant for several pharmaceutical companies interested in developing drugs for the treatment of fatty liver disease: Sanofi-Aventis, Astellas and Pfizer. SAH has acted as a consultant for several pharmaceutical companies interested in developing drugs for the treatment of non-alcoholic fatty liver disease: Sanofi-Aventis and Schering-Plough.